Literature DB >> 4362620

Subacute sclerosing panencephalitis. Elevated Epstein-Barr virus antibody titers and failure of amantadine therapy.

J Joncas, G Geoffroy, B McLaughlin, G Albert, N Lapointe, P David, R Lafontaine, M Granger-Julien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4362620     DOI： 10.1016/0022-510x(74)90040-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  6 in total

1.  Stimulation of antibodies to Epstein-Barr virus (EBV) in acute viral infections.

Authors:  T Gotlieb-Stematsky; L Rannon; A Vonsover; N Varsano
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  Letter: Interferon in serum and cerebrospinal fluid in subacute sclerosing panencephalitis.

Authors:  J H Joncas; L R Robillard; A Boudreault; M Leyritz; B J McLaughlin
Journal:  Can Med Assoc J       Date:  1976-08-21       Impact factor: 8.262

3.  Unusual features in a case diagnosed as subacute sclerosing panencephalitis (SSPE).

Authors:  K A Flügel; A Barocka; H Woelk
Journal:  J Neurol       Date:  1979-10       Impact factor: 4.849

4.  Mononucleosis-associated subacute sclerosing panencephalitis.

Authors:  F H Hochberg; J R Lehrich; E P Richardson; P Feorino; K E Aström
Journal:  Acta Neuropathol       Date:  1976-01-31       Impact factor: 17.088

5.  Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.

Authors:  W Sheremata; A Sazant; G Watters
Journal:  Can Med Assoc J       Date:  1978-03-04       Impact factor: 8.262

6.  Serological studies on the etiological role of measles-like virus in subacute sclerosing panencephalitis.

Authors:  I Polna; W Cendrowski
Journal:  J Neurol       Date:  1977-11-01       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.